NCT04451967

Brief Summary

This is a real-world prospective cohort study aiming to generate knowledge about the characteristics, treatments, and outcomes of hospitalized AMI patients in Jilin Province. The study includes hospitalizations diagnosed of AMI, including ST segment-elevation myocardial infarction (STEMI) and non-ST-segment-elevation myocardial infarction (NSTEMI).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,159

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 9, 2019

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

June 26, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 30, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 9, 2020

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 9, 2022

Completed
Last Updated

June 30, 2020

Status Verified

June 1, 2020

Enrollment Period

1 year

First QC Date

June 26, 2020

Last Update Submit

June 29, 2020

Conditions

Acute Myocardial Infarction

Outcome Measures

Primary Outcomes (1)

  • all-cause death

    all-cause death

    2 years post discharge

Secondary Outcomes (1)

  • major adverse cardiac events (MACE)

    2 years post discharge

Study Arms (3)

Transfer after thrombolysis

Procedure: thrombolysis

Transfer after DAPT

Direct transfer

Interventions

thrombolysisPROCEDURE

transfer after thrombolysis for STEMI patients within 6h since onset

Also known as: DAPT
Transfer after thrombolysis

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Eligible patients must be admitted within 7 days of acute myocardial ischemic symptoms with a primary clinical diagnosis of AMI, including ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI). Final inclusion criteria must meet Fourth Universal Definition for Myocardial Infarction (2018)

You may qualify if:

  • patients admitted within 7 days of acute myocardial ischemic symptoms with a primary clinical diagnosis of AMI, meet Fourth Universal Definition for Myocardial Infarction (2018)

You may not qualify if:

  • Types 4a and type 5 AMI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The second hospital of Jilin university

Changchun, Jilin, 130041, China

RECRUITING

Related Publications (1)

  • Li T, Wu J, Liu J, Sun W, Qi C, Liu B, Wells GA, Wang J; Acute Myocardial Infarction Study in Northeastern China (AMINoC). Protocol for the Acute Myocardial Infarction Study in Northeastern China (AMINoC): a real-world prospective cohort study. BMJ Open. 2021 May 25;11(5):e042936. doi: 10.1136/bmjopen-2020-042936.

    PMID: 34035090DERIVED

MeSH Terms

Interventions

Fibrinolytic Agents

Intervention Hierarchy (Ancestors)

Fibrin Modulating AgentsMolecular Mechanisms of Pharmacological ActionPharmacologic ActionsChemical Actions and UsesCardiovascular AgentsTherapeutic UsesHematologic Agents

Study Officials

  • Bin Liu, Ph.D

    Second Hospital of Jilin University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tianyi Li, Ph.D

CONTACT

+8615843024731litianyi@jlu.edu.cn

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 26, 2020

First Posted

June 30, 2020

Study Start

September 9, 2019

Primary Completion

September 9, 2020

Study Completion

September 9, 2022

Last Updated

June 30, 2020

Record last verified: 2020-06

Locations

CN(1)